Diagnostics & Research
The Diagnostics & Research industry has a total of 61 stocks, with a combined market cap of $719.78 billion, total revenue of $156.1 billion and a weighted average PE ratio of 54.42.
Market Cap
719.78B
Revenue
156.10B
Profits
13.23B
PE Ratio
54.42
Profit Margin
8.47%
Dividend Yield
0.21%
61 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 203.81B | -1.44% | 1,315,041 | 42.49B |
| 2 | DHR | Danaher Corporation | 178.07B | -1.68% | 5,062,755 | 22.52B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 39.41B | 0.17% | 402,180 | 3.72B |
| 4 | IQV | IQVIA Holdings Inc. | 37.80B | -0.49% | 876,646 | 15.07B |
| 5 | A | Agilent Technologies, Inc. | 36.70B | -1.09% | 1,382,912 | 6.59B |
| 6 | MTD | Mettler-Toledo International Inc. | 28.98B | -0.71% | 108,493 | 3.79B |
| 7 | ICLR | ICON PLC | 26.32B | 0.57% | 621,109 | 8.23B |
| 8 | LH | Labcorp Holdings Inc. | 17.09B | -0.20% | 394,843 | 12.30B |
| 9 | WAT | Waters Corporation | 16.88B | 0.63% | 323,312 | 2.91B |
| 10 | ILMN | Illumina, Inc. | 16.81B | 0.01% | 2,397,720 | 4.49B |
| 11 | DGX | Quest Diagnostics Incorporated | 15.18B | -0.33% | 982,210 | 9.29B |
| 12 | NTRA | Natera, Inc. | 13.59B | 2.68% | 865,482 | 1.21B |
| 13 | RVTY | Revvity, Inc. | 12.59B | -0.96% | 580,369 | 2.73B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.53B | -0.69% | 197,372 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 10.38B | -0.87% | 422,006 | 4.11B |
| 16 | QGEN | Qiagen N.V. | 9.03B | 1.17% | 572,731 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 7.97B | 1.74% | 1,794,533 | 2.53B |
| 18 | TEM | Tempus AI, Inc. | 5.94B | 7.92% | 720,546 | 562.02M |
| 19 | RDNT | RadNet, Inc. | 4.40B | 1.67% | 378,568 | 1.66B |
| 20 | GH | Guardant Health, Inc. | 3.53B | 2.16% | 690,044 | 603.73M |
| 21 | SHC | Sotera Health Company | 3.29B | 0.43% | 669,824 | 1.08B |
| 22 | NEOG | Neogen Corporation | 3.28B | 0.60% | 1,315,444 | 929.24M |
| 23 | OLK | Olink Holding AB (publ) | 3.20B | 0.70% | 1,547,877 | 170.89M |
| 24 | TWST | Twist Bioscience Corporation | 2.76B | -3.29% | 899,026 | 277.49M |
| 25 | MYGN | Myriad Genetics, Inc. | 2.24B | 3.30% | 775,699 | 774.20M |
| 26 | NEO | NeoGenomics, Inc. | 1.75B | -1.44% | 542,280 | 610.66M |
| 27 | VCYT | Veracyte, Inc. | 1.63B | -0.33% | 574,463 | 375.47M |
| 28 | OPK | OPKO Health, Inc. | 843.36M | -1.63% | 1,347,680 | 799.60M |
| 29 | CDNA | CareDx, Inc | 776.05M | -3.12% | 398,533 | 275.11M |
| 30 | FLGT | Fulgent Genetics, Inc. | 597.89M | -0.30% | 131,532 | 287.53M |
| 31 | CSTL | Castle Biosciences, Inc. | 586.93M | 0.33% | 194,749 | 250.73M |
| 32 | GRAL | GRAIL, Inc. Common Stock When Issued | 468.06M | 0.60% | 1,810,814 | - |
| 33 | ME | 23andMe Holding Co. | 192.08M | 4.15% | 3,911,173 | 219.64M |
| 34 | BDSX | Biodesix, Inc. | 181.20M | 3.27% | 126,315 | 54.85M |
| 35 | FONR | FONAR Corporation | 100.62M | -1.49% | 10,839 | 102.72M |
| 36 | ACRS | Aclaris Therapeutics, Inc. | 81.24M | -0.87% | 641,145 | 31.12M |
| 37 | TTOO | T2 Biosystems, Inc. | 78.06M | -5.58% | 93,383 | 7.18M |
| 38 | PRPH | ProPhase Labs, Inc. | 72.50M | -6.40% | 25,220 | 28.72M |
| 39 | PRE | Prenetics Global Limited | 70.98M | 9.09% | 5,885 | 10.61M |
| 40 | BNR | Burning Rock Biotech Limited | 63.46M | -1.35% | 676 | 72.30M |
| 41 | PSNL | Personalis, Inc. | 62.33M | 0.42% | 86,261 | 74.15M |
| 42 | MDXH | MDxHealth SA | 61.94M | -3.81% | 20,635 | 75.33M |
| 43 | ENZ | Enzo Biochem, Inc. | 55.06M | -3.60% | 24,964 | 4.72M |
| 44 | STIM | Neuronetics, Inc. | 52.50M | - | 57,990 | 73.23M |
| 45 | VNRX | VolitionRx Limited | 52.24M | 1.78% | 52,604 | 797.03K |
| 46 | NOTV | Inotiv, Inc. | 41.81M | 1.26% | 408,926 | 552.74M |
| 47 | OCX | OncoCyte Corporation | 39.56M | 0.34% | 44,533 | 1.38M |
| 48 | XGN | Exagen Inc. | 30.92M | -1.66% | 17,820 | 55.73M |
| 49 | BIAF | bioAffinity Technologies, Inc. | 25.30M | -2.25% | 54,323 | 4.94M |
| 50 | PMD | Psychemedics Corporation | 13.64M | -0.84% | 6,243 | 21.60M |
| 51 | AWH | Aspira Women's Health Inc. | 12.82M | 4.04% | 693,694 | 8.99M |
| 52 | STRR | Star Equity Holdings, Inc. | 12.55M | -9.17% | 24,534 | 42.56M |
| 53 | CNTG | Centogene N.V. | 11.89M | - | 11,367 | 53.93M |
| 54 | CHEK | Check-Cap Ltd. | 11.76M | -0.99% | 17,462 | - |
| 55 | MYNZ | Mainz Biomed B.V. | 7.42M | -1.80% | 562,753 | 895.48K |
| 56 | PRPO | Precipio, Inc. | 7.35M | -7.06% | 11,147 | 15.81M |
| 57 | XWEL | XWELL, Inc. | 7.28M | -1.14% | 6,392 | 31.77M |
| 58 | NDRA | ENDRA Life Sciences Inc. | 6.27M | -3.88% | 5,605,154 | - |
| 59 | GENE | Genetic Technologies Limited | 6.04M | -2.84% | 24,829 | 5.78M |
| 60 | ISPC | iSpecimen Inc. | 3.85M | -2.74% | 181,107 | 9.27M |
| 61 | APDN | Applied DNA Sciences, Inc. | 433.38K | -19.25% | 1,802,350 | 5.52M |